*4.1.4 Inadequate common profile*

#### **Possible reasons**

**Possible coping strategies**

• Establishing a long-term strategy for financing

*4.1.2 Incorrectly defined collection strategy according to bio specimens*

• An insufficient adaptation of the list of collection criteria

• Samples are not used or useable in scientific projects

and obligations for scientific leadership

• An insufficient trained personnel

partners

*Overview: risks in biobanking.*

*Risk Management and Assessment*

**Figure 6.**

**Possible reasons**

storage

**82**

**Possible consequences**

• Regular information exchange with the funding organization and cooperative

• Close cooperation in establishing and implementation of the collection strategy

• Developing general conditions for collection strategies and developing rights

• An insufficient infrastructure and/or instrument-qualifications for labs and

• Lack of personnel—not enough time for PR activities

#### **Possible consequences**

• Less projects—less project requests ! risk of interruption of third-party funding

#### **Possible coping strategies**


#### *4.1.5 A bad strategy for public relation activities for the donors*


• Low level of awareness and transparancy (e.g. by a lack of public events and publications)

*4.1.7 Wrong assessment of the stakeholder analysis*

*DOI: http://dx.doi.org/10.5772/intechopen.91463*

• Misestimating the importance of individual stakeholders

• Lack of farsightedness of operational management

• Loss of possible funding by specific stakeholders

• Less favourable political standing and/or support

• Stakeholder analysis with all levels of management including carrier

and politics with an intention to complete the analysis

• New standards in biobanking and the pre-analytical field

strategy of renewal of assessment after each year

*4.1.8 New strategic trends in the market of biobanking*

• Discussion of first results with key players internally/externally, researchers,

• Repeating first assessment, e.g., after 3 and 6 months, and implementing a

• Investigation of such analysis of comparable institutions and other local

• Population health-driven trends (novel infectious agents, healthy aging

• Newly appointed (external) personnel without knowledge of internal/external

**Possible reasons**

*Risk Management in Biobanks*

dependencies

• Bad image

**Possible consequences**

• Loss of sources of sample/data

**Possible coping strategies**

cooperation partners

• New research technology

• New hot topics in science

**Possible consequences**

• Being out of trend

**85**

research and/or fertility research)

• Less projects—less project requests

• Risk of interruption of third-party funding

**Possible reasons**

organization and environment
